Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THARROS: BGF vs GFF on Cardiopulmonary Outcomes in COPD
NCT06283966Phase 3Recruiting
- Sponsor
- AstraZeneca
- Start
- Feb 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 37
01
Overview
A Phase 3 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Feb 2024; status: recruiting.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06283966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06283966.